secwatch.observer — SEC 8-K summary
======================================

Issuer:     ORTHOPEDIATRICS CORP (KIDS)
CIK:        0001425450
Form:       8-K
Filed at:   2023-02-28T23:59:59+00:00
Accession:  0001425450-23-000018
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

OrthoPediatrics Q4 revenue up 25% to $31M; guides FY2023 revenue $146-149M
--------------------------------------------------------------------------

- Q4 2022 revenue $31.0M (+25% YoY); FY2022 revenue $122.3M (+25% vs 2021).
- GAAP net loss in Q4 $7.8M ($0.35/share) vs net income $0.1M in Q4 2021; FY2022 net income $1.3M ($0.06/share).
- Adjusted EBITDA loss $2.2M in Q4 vs loss $0.6M a year ago; FY2022 adjusted EBITDA positive $0.2M.
- Trauma & Deformity segment Q4 revenue $22.1M (+34% YoY); Scoliosis $8.0M (+12%); Sports Med/Other $0.9M (-22%).
- International revenue grew 67% in Q4 and 47% for FY2022; cash $119.8M at Dec 31, 2022.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1425450/000142545023000018/0001425450-23-000018-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1425450/000142545023000018/kids-20230228.htm
  HTML page:      https://secwatch.observer/filing/0001425450-23-000018

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer